SCHEMBL20983252

SCHEMBL20983252

CNC(=O)c1cc(C(=O)NC2CC2CCN2CCOCC2)cc2c1O[C@H](CF)[C@H]2c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 20/20 0.74
▸ TRIM24 O15164 1/20 0.64
▸ BRD1 O95696 1/20 0.64
▸ CCL2 P13500 1/20 0.64
▸ DRD2 P14416 1/20 0.64
▸ TAF1 P21675 1/20 0.64
▸ DRD4 P21917 1/20 0.64
▸ BRD2 P25440 1/20 0.64
▸ DRD3 P35462 1/20 0.64
▸ SMARCA2 P51531 1/20 0.64
▸ SMARCA4 P51532 1/20 0.64
▸ BRPF1 P55201 1/20 0.64
▸ EP300 Q09472 1/20 0.64
▸ BPTF Q12830 1/20 0.64
▸ BRD3 Q15059 1/20 0.64
▸ BRDT Q58F21 1/20 0.64
▸ ATAD2 Q6PL18 1/20 0.64
▸ PBRM1 Q86U86 1/20 0.64
▸ TAF1L Q8IZX4 1/20 0.64
▸ CREBBP Q92793 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19456353 1.00 BRD4 (0.74) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL20983266 0.90 BRD4 (0.62) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL21649918 0.90 BRD4 (0.62) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL19456317 0.90 BRD4 (0.62) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL20983263 0.90 BRD4 (0.62) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL20983297 0.90 BRD4 (0.62) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL21024098 0.87 BRD4 (0.55) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL21023958 0.87 BRD4 (0.87) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL20983264 0.87 BRD4 (0.87) BRD4TRIM24BRD1CCL2DRD2
SCHEMBL21023792 0.87 BRD4 (0.87) BRD4TRIM24BRD1CCL2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10583112-B2 Benzo[b]furans as bromodomain inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2020-03-10 — — US claimed
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2019-05-23 — — US claimed
US-10583112-B2 Benzo[b]furans as bromodomain inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2020-03-10 — — US disclosed
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10583112-B2 Benzo[b]furans as bromodomain inhibitors BRD4, BRD3, BRD2 BRD4 1/4885TRIM24 3150/4885BRD1 4/4885
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS BRD4, BRD3, BRD2 BRD4 1/4885TRIM24 3150/4885BRD1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback